Endonovo Therapeutics, Inc. (ENDV)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Endonovo Therapeutics Cash from Operations (Quarterly) : -0.0498M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0498M |
| March 31, 2026 | -0.0496M |
| December 31, 2025 | -0.0084M |
| September 30, 2025 | -0.0095M |
| June 30, 2025 | -0.0248M |
| March 31, 2025 | -0.0002M |
| December 31, 2024 | 0.1028M |
| September 30, 2024 | -0.0011M |
| June 30, 2024 | 0.001M |
| March 31, 2024 | -0.0022M |
| December 31, 2023 | 0.5262M |
| September 30, 2023 | -0.0654M |
| June 30, 2023 | -0.1658M |
| March 31, 2023 | -0.1732M |
| December 31, 2022 | -0.2255M |
| September 30, 2022 | -0.1239M |
| June 30, 2022 | -0.2065M |
| March 31, 2022 | -0.123M |
| December 31, 2021 | -0.3913M |
| September 30, 2021 | -0.1694M |
| June 30, 2021 | -0.1359M |
| March 31, 2021 | -0.2899M |
| December 31, 2020 | -0.1929M |
| September 30, 2020 | -0.0967M |
| June 30, 2020 | -0.1548M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2972M |
| December 31, 2019 | -0.3084M |
| September 30, 2019 | -1.017M |
| June 30, 2019 | -0.6876M |
| March 31, 2019 | -0.5282M |
| December 31, 2018 | -0.7161M |
| September 30, 2018 | -0.8304M |
| June 30, 2018 | -0.7416M |
| March 31, 2018 | -0.5908M |
| December 31, 2017 | -0.8006M |
| September 30, 2017 | -0.8414M |
| June 30, 2017 | -0.9136M |
| March 31, 2017 | -0.4342M |
| December 31, 2016 | -0.6586M |
| September 30, 2016 | -0.7756M |
| June 30, 2016 | -0.577M |
| March 31, 2016 | -0.4511M |
| December 31, 2015 | -0.2231M |
| September 30, 2015 | -0.4292M |
| June 30, 2015 | -0.185M |
| March 31, 2015 | -0.1938M |
| December 31, 2014 | -0.2277M |
| September 30, 2014 | -0.1961M |
| June 30, 2014 | -0.2895M |
| March 31, 2014 | -0.1959M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.684M |
| Accuray, Inc. | 2.427M |
| Micron Solutions, Inc. | -- |
| Perspective Therapeutics, Inc. | -20.65M |
| Orthofix Medical, Inc. | -6.147M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.075M |
| Free Cash Flow | -0.1174M |
| Free Cash Flow to Equity (Quarterly) | -0.1248M |
| Free Cash Flow to Firm (Quarterly) | 0.2595M |
| Free Cash Flow Yield | -129.9% |